L'Oréal leads €35 million funding for French biotech firm Abolis

By Alessandro Carrara | Published: 13-Sep-2024

Abolis is a biotech innovator which creates ‘sustainable’ and microbe-powered beauty solutions for the industry

You need to be a subscriber to read this article.
Click here to find out more.

L'Oréal has led a €35m funding round for French biotech ingredients company Abolis.

The investment will be used to expand the Essone-based company’s development of microbe-based beauty solutions.

Biotech is a key driver in the transformation of L'Oréal’s ingredient portfolio, Anne Colonna, Global Head of Advanced Research at L’Oréal, told Cosmetics Business

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like